iCAD to Showcase New CAD Innovations at RSNA 2007
NASHUA, N.H., Nov. 14 / - iCAD, Inc. (NASDAQ:ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced it will unveil its latest CAD innovations for more than 60,000 industry experts attending the Radiological Society of North America (RSNA)'s Annual Meeting in Chicago, November 25-30 (booth #3507).
At the meeting, iCAD will provide demonstrations of its SecondLook® suite of products, including its most recent developments that showcase SecondLook Digital's unique compatibility with industry leading Full-Field Digital Mammography (FFDM) and Computed Radiography (CR) solutions. iCAD's latest innovations deliver powerful performance improvements increasing the radiologist's confidence of findings while enhancing workflow. iCAD will also feature CAD applications for tomosynthesis and CT colonography that are currently under development.
"iCAD sees a wide range of application opportunities for CAD, and the RSNA is the ideal venue to share our vision for the direction of the technology with key industry leaders. Our expanded and enhanced mammography solutions coupled with new development areas, such as CT colonography, will help drive the future of CAD," said Ken Ferry, Chief Executive Officer of iCAD, Inc. "As facilities look to expand their CAD offerings, iCAD's proven interoperability makes it an ideal choice for both large and small scale implementations."
iCAD offers high-performance CAD solutions for both digital and film-based mammography systems. iCAD's systems are based on sophisticated algorithms that analyze the data; automatically identifying and marking suspicious regions in the images. The result is earlier detection of hard-to-find cancers, improved workflow for radiologists, and higher quality patient care.
Additionally, iCAD is developing CAD solutions for use with virtual colonoscopy to improve the detection of colonic polyps. By focusing on superior identification capabilities, iCAD's system for virtual colonoscopy is designed to assist in improving accuracy and workflow during the reading process.
About iCAD, Inc.
iCAD, Inc. (NASDAQ:ICAD) is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or
via email at ddeptula@icadmed.com
For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications
at 781-684-0770 or via email at icad@schwartz-pr.com
FCMN Contact: atuttle-melgar@schwartz-pr.com
Source: iCAD, Inc.
Web site: www.icadmed.com/
